FDA Issues Vision Loss Warning for Popular Diabetes Drugs Ozempic, Wegovy

The FDA has issued a new warning about potential vision loss associated with the use of Ozempic and Wegovy. Both drugs are injectable medications used to treat type 2 diabetes. While they are effective in managing blood sugar levels, the FDA is now advising patients to be aware of the possibility of vision problems as a side effect. The agency recommends that patients experiencing any changes in vision while taking these medications should immediately consult their healthcare provider. The FDA is currently investigating the potential link between these drugs and vision loss, and further information will be released as it becomes available.